发明名称 Controlled release formulations of orally-active medicaments
摘要 An improved tablet formulation is provided comprising an effective amount of an active therapeutic agent, especially an acidic therapeutic agent such as aspirin, a release-controlling agent, and an erosion-promoting agent in relative amounts to provide a criticality factor of less than 450, and in proportions of release-controlling and erosion-promoting agent, respectively, between 0.8-1.6 and 1.0-7.5 weight percent per tablet. The tablets of this invention exhibit zero order release in vitro and closely approximate zero order absorption in vivo. The aspirin tablets of the invention produce minimal epigastric distress and can be administered twice-a-day to provide the desired therapeutic effect. The preferred release-controlling agent is cellulose acetate phthalate and the preferred erosion-promoting agent is corn starch.
申请公布号 US4308251(A) 申请公布日期 1981.12.29
申请号 US19800194453 申请日期 1980.10.17
申请人 BOOTS PHARMACEUTICALS, INC. 发明人 DUNN, JAMES M.;LAMPARD, JOHN F.
分类号 A61K9/20;(IPC1-7):A61K9/22;A61K9/30;A61K9/52;A61K9/56 主分类号 A61K9/20
代理机构 代理人
主权项
地址